Related Experiment Video
Updated: Jun 19, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
The Role of Matrix Metalloproteinases in Liver Function and Disease
Gregoria Mitropoulou1, Vasiliki Kompoura1, Francesca Saffioti2,3,4,5
1Laboratory of Applied Microbiology and Biotechnology, Department of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Abstract:
Matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinases (TIMPs) play critical roles in the pathogenesis of liver diseases, particularly in conditions such as fibrosis, cirrhosis, and liver cancer. This review highlights the diagnostic and prognostic potential of MMPs, emphasizing their involvement in metastasis, de-differentiation, and hepatic cell proliferation. Utilizing advanced reporter mouse models has proven instrumental in assessing intraglandular MMP activity and predicting metastatic risks, paving the way for targeted therapeutic interventions. Current research indicates that specific MMPs and TIMPs can serve as valuable biomarkers for liver function and disease progression, although a clear consensus on their clinical utility remains elusive. Ongoing studies explore MMP-targeted therapies with potential applications in liver disease management, particularly in reducing fibrosis and enhancing liver regeneration. Future directions in this field involve elucidating the roles of MMPs in ischemia and transplantation, with the aim of improving clinical outcomes. Emerging therapeutic strategies focus on achieving a balance between MMP activity and TIMP expression to optimize liver function, highlighting the need for organ-specific targeting. Overall, this comprehensive overview underscores the importance of MMPs and TIMPs in liver function and liver disease, as well as the necessity for further research to harness their potential in clinical practice.
Insights
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are key in liver disease. Research shows their potential as biomarkers and therapeutic targets for liver fibrosis, cancer, and regeneration.
Area of Science:
- Biochemistry
- Molecular Biology
- Hepatology
Background:
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are crucial in liver disease pathogenesis, including fibrosis, cirrhosis, and cancer.
- Their roles extend to metastasis, de-differentiation, and hepatic cell proliferation, impacting disease progression.
Purpose of the Study:
- To review the diagnostic and prognostic potential of MMPs and TIMPs in liver diseases.
- To highlight their involvement in key pathological processes and their utility as biomarkers.
- To discuss current and future therapeutic strategies targeting MMPs and TIMPs for liver disease management.
Main Methods:
- Review of current literature on MMPs and TIMPs in liver diseases.
- Analysis of data from advanced reporter mouse models for assessing MMP activity and metastatic risk.
- Exploration of ongoing research into MMP-targeted therapies and biomarker development.
Main Results:
- MMPs and TIMPs are implicated in liver fibrosis, cirrhosis, and cancer progression.
- Reporter mouse models aid in evaluating MMP activity and predicting metastatic potential.
- Specific MMPs and TIMPs show promise as biomarkers for liver function and disease, though clinical consensus is pending.
Conclusions:
- MMPs and TIMPs are vital in liver function and disease, offering diagnostic, prognostic, and therapeutic potential.
- Targeted therapies aiming to balance MMP activity and TIMP expression are under investigation for liver disease management.
- Further research is needed to fully elucidate their roles, particularly in ischemia and transplantation, to improve clinical outcomes.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Cirrhosis II: Pathophysiology
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

